DCM
CBIO

DAFNA Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

DAFNA Capital Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-280
Closed -$204K – 87
2016
Q2 		$204K Buy
+280
New +$204K 0.16% 77